The Office of Inspector General (OIG) announced it will audit CMS’ use of remote patient monitoring services. The review will focus on the nature of these services, as well as the characteristics of Medicare enrollees who use them.
Medicare could have saved over $200 million in payments for definitive drug testing services between 2016 and 2020 if proper program safeguards had been in place, according to a recent audit report by the Office of Inspector General (OIG).
